Targeting a specialized group of histones is safe and opens new therapeutic opportunities for treating blood cancers. This is the main finding of the latest research by Dr. Marcus Buschbeck and Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback